Alcidion Group Limited · ASX:ALC
Alcidion — Investor Presentation (May 2019)
16 slides from Alcidion's investor presentation, May 1, 2019
Slide 1: Investor Presentation: Enabling the transformation of healthcare
For personal use only Investor Presentation Enabling the transformation of healthcare Kate Quirke, Group Managing Director May 2019 1
Slide 2: The delivery of healthcare is changing
The delivery of healthcare is changing For personal use only More data doesn’t mean improved productivity or quality information for decision making: This is our opportunity • Increased spending on digital patient data has led to a decrease in productivity • Clinical risk and avoidable errors remain
Slide 3: The Alcidion business today
The Alcidion business today For personal use only Smart collection of clinical observations and UK: 14 customer patient data, clinical communication and AI driven contracts covering decision support systems 31 hospitals Fully integrated platform underpinned by leading edge, adaptable, platform techn
Slide 4: The Alcidion Difference
The Alcidion Difference • Big single solution EMR is not the answer For personal use only • care team productivity can drop by 20-30% • stifles innovation and hostage to one vendor solution • We have the platform to transform healthcare • Miya Precision is an innovative events driven platform • comb
Slide 5: Miya Precision
Miya Precision For personal use only EMR, PAS Hospital Acquired Complications & Critical Clinical risk, Clinical App, Results Predictive Smartpage Labs, Radiology Specialty Complexity & Specific Views, Patient Flow Coding EMR Integration Medications, Orders Real-Time Dashboards, Real-Time 3rd Party
Slide 6: Miya Precision Target Workflow
Miya Precision Target Workflow For personal use only Clinician is presented with key information from years of data The clinician takes observations, orders Critical new information tests and writes notes in Tasks and referrals are is sent using smart the EMR automated notifications Patient arrives
Slide 7: Clinical App
For personal use only Clinical App Smartpage Patientrack Specialty Specific Views, Integrated to EMR Real-Time Dashboards Hospital Operations
Slide 8: From this to This
From this…………………………………..To This For personal use only 8
Slide 9: Market opportunity – AU, NZ, UK
Market opportunity – AU, NZ, UK For personal use only • International expansion initially Market adoption remains at an early stage with strong global growth drivers including need to eliminate focused where current customers preventable patient deaths and avoidable cardiac arrests exist - AU, NZ an
Slide 10: The Competitive Landscape
The Competitive Landscape For personal use only Category Usage How Alcidion compares / complements Major Players We help customers realise the value to these large, • Currently installed in most states of Australia EPIC transactional based systems through application of and in a number of NHS Trusts
Slide 11: An emerging leader in healthcare analytics
An emerging leader in healthcare analytics For personal use only Acquisitions completed First integrated Miya Delivered positive First UK contract $15.9M contracted MKM Patientrack operational cash flow for announced for revenue to be realised in Health/Patientrack and Smartpage contract H1 FY19, wi
Slide 12: Q3 FY2019 Highlights
Q3 FY2019 Highlights For personal use only Alcidion Group FY19 Contracted Revenue Q3 FY2019 results demonstrated continued growth in sales, Recurring vs Non-recurring (m) 18 added contracted revenue, positive net cash inflow and boost FY19 Sold (Contracted) Revenue 16 to cash reserves. 14 • Positive
Slide 13: Growth strategy
Growth strategy For personal use only Integration Cross-selling to existing customer base • Focus on key reference sites & established customers • Roles and products integrated • Grow pipeline • Brand consolidation project started • Speed up pipeline conversion • One Company from July 1 Technology e
Slide 14: Why invest in Alcidion
Why invest in Alcidion • Large market opportunity and the right context – digital patient data is For personal use only driving demand for better healthcare analytics • A leading-edge technology suite – increasingly looked upon as a strategic solution for improving healthcare delivery • Differentiat
Slide 15: Company snapshot
Company snapshot Capital Structure Major Shareholders For personal use only Name Shares Held % issued shares Ordinary shares on issue 805.7m Malcolm Pradhan 134.6m 16.7% Share price (30/04/19) 0.094 Ray Blight 95.8m 11.9% Isle of Wight Pty Ltd Market capitalisation $75.7m 43.2m 5.4% (Colin Mackinnon
Slide 16: Contacts
Contacts For personal use only Kyahn Williamson Head of Investor Communication WE Buchan kwilliamson@we-buchan.com +61 401 018 828 16